Shen Zhao

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 6 篇 · 总被引 90 次 · h-index 4

代表论文

• The next generation of immunotherapies for lung cancers (2025 · Nature Reviews Clinical Oncology · 被引 69)
• Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial (2024 · Journal of Thoracic Oncology · 被引 7)
• Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (2026 · JAMA Oncology · 被引 6)
• Safety and efficacy of iparomlimab and tuvonralimab in combination with gemcitabine and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase 2 trial (DUBHE-N-302). (2024 · Journal of Clinical Oncology · 被引 4)
• Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study (2023 · Clinical Lung Cancer · 被引 3)
• First-in-human trial of SYS6010 combined with SYH2051 in patients with advanced gastrointestinal tumors. (2025 · Journal of Clinical Oncology · 被引 1)